{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:36:47Z","timestamp":1790037407199,"version":"4.0.1"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Southwestern Medical University China","award":["MEPSCKL201301"],"award-info":[{"award-number":["MEPSCKL201301"]}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["2016, 2018"],"award-info":[{"award-number":["2016, 2018"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Loo och Hans Ostermans Stiftelse","award":["2018-01213"],"award-info":[{"award-number":["2018-01213"]}]},{"name":"Thorax of Karolinska University Hospital"},{"name":"Sigurt and Elsa Goljes Memorial Foundation"},{"name":"Lars Hiertas Minne Foundation","award":["FO2018-0156"],"award-info":[{"award-number":["FO2018-0156"]}]},{"name":"Lars Hiertas Minne Foundation","award":["NIH-HL027339"],"award-info":[{"award-number":["NIH-HL027339"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.phrs.2018.12.009","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T13:04:39Z","timestamp":1544706279000},"page":"32-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5107-6529","authenticated-orcid":false,"given":"Zhichao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pernow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4677-6392","authenticated-orcid":false,"given":"S. Jamal","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2836-2241","authenticated-orcid":false,"given":"Dirk J.","family":"Duncker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4852-831X","authenticated-orcid":false,"given":"Daphne","family":"Merkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2018.12.009_bib0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1358\/dnp.2003.16.3.876886","article-title":"Involvement of purinergic signaling in cardiovascular diseases","volume":"16","author":"Ralevic","year":"2003","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.phrs.2018.12.009_bib0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autneu.2015.04.007","article-title":"Purinergic transmission in blood vessels","volume":"191","author":"Ralevic","year":"2015","journal-title":"Auton. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2018.12.009_bib0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1476-5381.2010.00937.x","article-title":"Control of vascular tone by purines and pyrimidines","volume":"161","author":"Burnstock","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2018.12.009_bib0020","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCRESAHA.108.177865","article-title":"Adenosine 5\u2019-tetraphosphate is a highly potent purinergic endothelium-derived vasoconstrictor","volume":"103","author":"Tolle","year":"2008","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.phrs.2018.12.009_bib0025","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1476-5381.2009.00337.x","article-title":"Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system","volume":"157","author":"Jankowski","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2018.12.009_bib0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nm1188","article-title":"Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor","volume":"11","author":"Jankowski","year":"2005","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.phrs.2018.12.009_bib0035","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00109-013-1036-y","article-title":"The enzymatic activity of the VEGFR2 receptor for the biosynthesis of dinucleoside polyphosphates","volume":"91","author":"Jankowski","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.phrs.2018.12.009_bib0040","article-title":"The role of uridine adenosine tetraphosphate in the vascular system","volume":"2011","author":"Matsumoto","year":"2011","journal-title":"Adv Pharmacol Sci"},{"key":"10.1016\/j.phrs.2018.12.009_bib0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.vph.2015.04.009","article-title":"Mechanisms underlying uridine adenosine tetraphosphate-induced vascular contraction in mouse aorta: role of thromboxane and purinergic receptors","volume":"73","author":"Zhou","year":"2015","journal-title":"Vascul Pharmacol"},{"issue":"4","key":"10.1016\/j.phrs.2018.12.009_bib0050","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11302-017-9586-z","article-title":"Divergent coronary flow responses to uridine adenosine tetraphosphate in atherosclerotic ApoE knockout mice","volume":"13","author":"Teng","year":"2017","journal-title":"Purinergic Signal"},{"issue":"8","key":"10.1016\/j.phrs.2018.12.009_bib0055","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/ATVBAHA.107.143958","article-title":"Increased uridine adenosine tetraphosphate concentrations in plasma of juvenile hypertensives","volume":"27","author":"Jankowski","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.phrs.2012.09.011","article-title":"Uridine adenosine tetraphosphate is a novel vasodilator in the coronary microcirculation which acts through purinergic P1 but not P2 receptors","volume":"67","author":"Zhou","year":"2013","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.phrs.2018.12.009_bib0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1748-1716.2010.02135.x","article-title":"Uridine adenosine tetraphosphate affects contractility of mouse aorta and decreases blood pressure in conscious rats and mice","volume":"200","author":"Hansen","year":"2010","journal-title":"Acta Physiol (Oxf)"},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0070","doi-asserted-by":"crossref","first-page":"H299","DOI":"10.1152\/ajpheart.00578.2015","article-title":"Uridine adenosine tetraphosphate acts as a proangiogenic factor in vitro through purinergic P2Y receptors","volume":"311","author":"Zhou","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"10.1016\/j.phrs.2018.12.009_bib0075","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/FJC.0b013e318231e929","article-title":"Signaling mechanisms mediating uridine adenosine tetraphosphate-induced proliferation of human vascular smooth muscle cells","volume":"58","author":"Gui","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2018.12.009_bib0080","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.bbrc.2011.12.088","article-title":"Uridine adenosine tetraphosphate (Up4A) is a strong inductor of smooth muscle cell migration via activation of the P2Y2 receptor and cross-communication to the PDGF receptor","volume":"417","author":"Wiedon","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.phrs.2018.12.009_bib0085","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ki.2011.326","article-title":"Uridine adenosine tetraphosphate activation of the purinergic receptor P2Y enhances in vitro vascular calcification","volume":"81","author":"Schuchardt","year":"2012","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.phrs.2018.12.009_bib0090","doi-asserted-by":"crossref","first-page":"H409","DOI":"10.1152\/ajpheart.00084.2011","article-title":"Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats","volume":"301","author":"Matsumoto","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.phrs.2011.09.005","article-title":"Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats","volume":"65","author":"Matsumoto","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2018.12.009_bib0100","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/ajh\/hpw163","article-title":"Impaired aortic contractility to uridine adenosine tetraphosphate in angiotensin II-induced hypertensive mice: receptor desensitization?","author":"Zhou","year":"2017","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.phrs.2018.12.009_bib0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fphar.2018.00255","article-title":"Uridine adenosine tetraphosphate-induced coronary relaxation is blunted in swine with pressure overload: a role for vasoconstrictor prostanoids","volume":"9","author":"Zhou","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2018.12.009_bib0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00424-013-1330-0","article-title":"Enhanced uridine adenosine tetraphosphate-induced contraction in renal artery from type 2 diabetic Goto-Kakizaki rats due to activated cyclooxygenase\/thromboxane receptor axis","volume":"466","author":"Matsumoto","year":"2014","journal-title":"Pflugers Arch"},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/rej.2015.1662","article-title":"Diabetes and age-related differences in vascular function of renal artery: possible involvement of endoplasmic reticulum stress","volume":"19","author":"Matsumoto","year":"2016","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.phrs.2018.12.009_bib0120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11302-017-9563-6","article-title":"Altered purinergic signaling in uridine adenosine tetraphosphate-induced coronary relaxation in swine with metabolic derangement","author":"Zhou","year":"2017","journal-title":"Purinergic Signal"},{"issue":"3","key":"10.1016\/j.phrs.2018.12.009_bib0125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00109-008-0306-6","article-title":"Uridine adenosine tetraphosphate acts as an autocrine hormone affecting glomerular filtration rate","volume":"86","author":"Jankowski","year":"2008","journal-title":"J Mol Med (Berl)"},{"issue":"5","key":"10.1016\/j.phrs.2018.12.009_bib0130","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1681\/ASN.2014010060","article-title":"Tubulovascular cross-talk by vascular endothelial growth factor a maintains peritubular microvasculature in kidney","volume":"26","author":"Dimke","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.phrs.2018.12.009_bib0135","doi-asserted-by":"crossref","first-page":"F905","DOI":"10.1152\/ajprenal.2000.278.6.F905","article-title":"Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells","volume":"278","author":"Kanellis","year":"2000","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"24","key":"10.1016\/j.phrs.2018.12.009_bib0140","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","article-title":"Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.phrs.2018.12.009_bib0145","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1158\/1078-0432.CCR-10-3109","article-title":"SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo","volume":"17","author":"Zhang","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.phrs.2018.12.009_bib0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0301-472X(02)00837-8","article-title":"The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells","volume":"30","author":"Spiekermann","year":"2002","journal-title":"Exp. Hematol."},{"issue":"11","key":"10.1016\/j.phrs.2018.12.009_bib0155","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1158\/0008-5472.CAN-07-6705","article-title":"Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice","volume":"68","author":"Dineen","year":"2008","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.phrs.2018.12.009_bib0160","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150019","article-title":"Identification of signalling cascades involved in red blood cell shrinkage and vesiculation","volume":"35","author":"Kostova","year":"2015","journal-title":"Biosci. Rep."},{"issue":"12","key":"10.1016\/j.phrs.2018.12.009_bib0165","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00018-007-6497-0","article-title":"Purine and pyrimidine receptors","volume":"64","author":"Burnstock","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11302-007-9078-7","article-title":"P2 receptors in cardiovascular regulation and disease","volume":"4","author":"Erlinge","year":"2008","journal-title":"Purinergic Signal"},{"issue":"5","key":"10.1016\/j.phrs.2018.12.009_bib0175","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1549-8719.2011.00158.x","article-title":"Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communication","volume":"19","author":"Sprague","year":"2012","journal-title":"Microcirculation"},{"issue":"4","key":"10.1016\/j.phrs.2018.12.009_bib0180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/BSR20080052","article-title":"Dinucleotide polyphosphates contribute to purinergic signalling via inhibition of adenylate kinase activity","volume":"28","author":"Yegutkin","year":"2008","journal-title":"Biosci. Rep."},{"issue":"6","key":"10.1016\/j.phrs.2018.12.009_bib0185","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/10409238.2014.953627","article-title":"Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities","volume":"49","author":"Yegutkin","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2018.12.009_bib0190","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11302-005-5302-5","article-title":"Physiological roles for ecto-5\u2019-nucleotidase (CD73)","volume":"2","author":"Colgan","year":"2006","journal-title":"Purinergic Signal"},{"issue":"4","key":"10.1016\/j.phrs.2018.12.009_bib0195","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11302-014-9425-4","article-title":"Expression of mediators of purinergic signaling in human liver cell lines","volume":"10","author":"Goree","year":"2014","journal-title":"Purinergic Signal"},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0200","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11302-013-9398-8","article-title":"Purinergic signalling in the liver in health and disease","volume":"10","author":"Burnstock","year":"2014","journal-title":"Purinergic Signal"},{"issue":"1-2","key":"10.1016\/j.phrs.2018.12.009_bib0205","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11302-006-9050-y","article-title":"CD39 and control of cellular immune responses","volume":"3","author":"Dwyer","year":"2007","journal-title":"Purinergic Signal"},{"issue":"6","key":"10.1016\/j.phrs.2018.12.009_bib0210","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.phrs.2018.12.009_bib0215","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1046\/j.1471-4159.2001.00480.x","article-title":"Multiple ecto-nucleotidases in PC12 cells: identification and cellular distribution after heterologous expression","volume":"78","author":"Vollmayer","year":"2001","journal-title":"J. Neurochem."},{"issue":"10 Suppl","key":"10.1016\/j.phrs.2018.12.009_bib0220","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1681\/ASN.V210s107","article-title":"Cell surface receptors and ectoenzymes in mesangial cells","volume":"2","author":"Ardaillou","year":"1992","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.phrs.2018.12.009_bib0225","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1902\/jop.2007.060283","article-title":"Extracellular ATP and ATPgammaS suppress the proliferation of human periodontal ligament cells by different mechanisms","volume":"78","author":"Kawase","year":"2007","journal-title":"J. Periodontol."},{"issue":"4-6","key":"10.1016\/j.phrs.2018.12.009_bib0230","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.vph.2008.03.003","article-title":"Uridine adenosine tetraphosphate induces contraction and relaxation in rat aorta","volume":"48","author":"Linder","year":"2008","journal-title":"Vascul Pharmacol"},{"issue":"4","key":"10.1016\/j.phrs.2018.12.009_bib0235","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0031-6997(25)06812-7","article-title":"Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization","volume":"46","author":"Dalziel","year":"1994","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0240","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pharmthera.2013.06.002","article-title":"Cardiovascular adenosine receptors: expression, actions and interactions","volume":"140","author":"Headrick","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2018.12.009_bib0245","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00109-013-1101-6","article-title":"Adenosine--a physiological or pathophysiological agent?","volume":"92","author":"Fredholm","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.phrs.2018.12.009_bib0250","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-3-540-89615-9_6","article-title":"Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology","volume":"193","author":"Mustafa","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2018.12.009_bib0255","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/pr.58.3.3","article-title":"International Union of pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy","volume":"58","author":"Abbracchio","year":"2006","journal-title":"Pharmacol Rev"},{"issue":"8","key":"10.1016\/j.phrs.2018.12.009_bib0260","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/1568026043451014","article-title":"Introduction: P2 receptors","volume":"4","author":"Burnstock","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2018.12.009_bib0265","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1570161114666151202204948","article-title":"Purinergic signalling and endothelium","volume":"14","author":"Burnstock","year":"2016","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2018.12.009_bib0270","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1124\/jpet.105.096610","article-title":"NADPH-induced contractions of mouse aorta do not involve NADPH oxidase: a role for P2X receptors","volume":"317","author":"Judkins","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2018.12.009_bib0275","doi-asserted-by":"crossref","first-page":"H1411","DOI":"10.1152\/ajpheart.00684.2004","article-title":"Role of A1 adenosine receptors in regulation of vascular tone","volume":"288","author":"Tawfik","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"10.1016\/j.phrs.2018.12.009_bib0280","doi-asserted-by":"crossref","first-page":"H2183","DOI":"10.1152\/ajpheart.00964.2001","article-title":"Targeted deletion of adenosine a(3) receptors augments adenosine-induced coronary flow in isolated mouse heart","volume":"282","author":"Talukder","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"13","key":"10.1016\/j.phrs.2018.12.009_bib0285","doi-asserted-by":"crossref","first-page":"7617","DOI":"10.1073\/pnas.121587098","article-title":"Heteromeric association creates a P2Y-like adenosine receptor","volume":"98","author":"Yoshioka","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.phrs.2018.12.009_bib0290","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0014-5793(02)03540-8","article-title":"Hetero-oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains","volume":"531","author":"Yoshioka","year":"2002","journal-title":"FEBS Lett."},{"issue":"411","key":"10.1016\/j.phrs.2018.12.009_bib0295","doi-asserted-by":"crossref","first-page":"ra7","DOI":"10.1126\/scisignal.aac9187","article-title":"Purinergic P2Y6 receptors heterodimerize with angiotensin AT1 receptors to promote angiotensin II-induced hypertension","volume":"9","author":"Nishimura","year":"2016","journal-title":"Sci. Signal."},{"issue":"2","key":"10.1016\/j.phrs.2018.12.009_bib0300","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0026-895X(24)12641-7","article-title":"Selective regulation of G protein-coupled receptor-mediated signaling by G protein-coupled receptor kinase 2 in FRTL-5 cells: analysis of thyrotropin, alpha(1B)-adrenergic, and a(1) adenosine receptor-mediated responses","volume":"56","author":"Iacovelli","year":"1999","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2018.12.009_bib0305","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0026-895X(25)10557-9","article-title":"Desensitization of the canine A2a adenosine receptor: delineation of multiple processes","volume":"45","author":"Palmer","year":"1994","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2018.12.009_bib0310","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.bbamem.2010.06.007","article-title":"Adenosine receptor desensitization and trafficking","volume":"1808","author":"Mundell","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0315","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/BST20120295","article-title":"Molecular mechanisms of platelet P2Y(12) receptor regulation","volume":"41","author":"Cunningham","year":"2013","journal-title":"Biochem. Soc. Trans."},{"issue":"2-3","key":"10.1016\/j.phrs.2018.12.009_bib0320","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0014-2999(97)89184-4","article-title":"Slow desensitization of the human P2Y6 receptor","volume":"329","author":"Robaye","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2018.12.009_bib0325","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/pr.110.003129","article-title":"Activation and regulation of purinergic P2X receptor channels","volume":"63","author":"Coddou","year":"2011","journal-title":"Pharmacol Rev"},{"issue":"37","key":"10.1016\/j.phrs.2018.12.009_bib0330","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.2174\/138161212803582504","article-title":"P2Y purinoceptors as potential emerging therapeutical target in vascular disease","volume":"18","author":"Schuchardt","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2018.12.009_bib0335","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fphar.2017.00661","article-title":"Purinergic signalling: therapeutic developments","volume":"8","author":"Burnstock","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11302-014-9436-1","article-title":"Cardiac purinergic signalling in health and disease","volume":"11","author":"Burnstock","year":"2015","journal-title":"Purinergic Signal"},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0345","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/pr.113.008029","article-title":"Purinergic signaling and blood vessels in health and disease","volume":"66","author":"Burnstock","year":"2014","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0350","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/CIRCRESAHA.116.309726","article-title":"Purinergic signaling in the cardiovascular system","volume":"120","author":"Burnstock","year":"2017","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.phrs.2018.12.009_bib0355","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/S0028-3908(00)00022-8","article-title":"The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor","volume":"39","author":"Rettinger","year":"2000","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.phrs.2018.12.009_bib0360","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112378","article-title":"Alteration of vascular responsiveness to uridine adenosine tetraphosphate in aortas isolated from male diabetic otsuka Long-Evans Tokushima fatty rats: the involvement of prostanoids","volume":"18","author":"Matsumoto","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2018.12.009_bib0365","doi-asserted-by":"crossref","first-page":"H3448","DOI":"10.1152\/ajpheart.00764.2007","article-title":"Involvement of COX-1 in A3 adenosine receptor-mediated contraction through endothelium in mice aorta","volume":"293","author":"Ansari","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.phrs.2018.12.009_bib0370","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3565(25)20406-2","article-title":"Adenosine and ATP produce vasoconstriction in the feline pulmonary vascular bed by different mechanisms","volume":"258","author":"Neely","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1-3","key":"10.1016\/j.phrs.2018.12.009_bib0375","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2006.10.050","article-title":"Mechanisms underlying ATP-induced endothelium-dependent contractions in the SHR aorta","volume":"556","author":"Gluais","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2018.12.009_bib0380","doi-asserted-by":"crossref","first-page":"L733","DOI":"10.1152\/ajplung.00403.2007","article-title":"Up4A stimulates endothelium-independent contraction of isolated rat pulmonary artery","volume":"294","author":"Gui","year":"2008","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.phrs.2018.12.009_bib0385","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.phrs.2013.08.007","article-title":"Blunted coronary vasodilator response to uridine adenosine tetraphosphate in post-infarct remodeled myocardium is due to reduced P1 receptor activation","volume":"77","author":"Zhou","year":"2013","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.phrs.2018.12.009_bib0390","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/sj.bjp.0703760","article-title":"Properties of P2X and P2Y receptors are dependent on artery diameter in the rat mesenteric bed","volume":"131","author":"Gitterman","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0395","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0531-5565(01)00159-0","article-title":"Age-related changes in P2 receptor mRNA of rat cerebral arteries","volume":"37","author":"Miao","year":"2001","journal-title":"Exp. Gerontol."},{"issue":"6752","key":"10.1016\/j.phrs.2018.12.009_bib0400","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/46816","article-title":"Cytochrome P450 2C is an EDHF synthase in coronary arteries","volume":"401","author":"Fisslthaler","year":"1999","journal-title":"Nature"},{"issue":"Pt 2","key":"10.1016\/j.phrs.2018.12.009_bib0405","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1113\/jphysiol.2007.143750","article-title":"Endothelium-derived hyperpolarizing factor as an in vivo back-up mechanism in the cutaneous microcirculation in old mice","volume":"585","author":"Gaubert","year":"2007","journal-title":"J Physiol"},{"issue":"8","key":"10.1016\/j.phrs.2018.12.009_bib0410","doi-asserted-by":"crossref","first-page":"H1747","DOI":"10.1152\/ajpheart.00648.2011","article-title":"Cytochrome P-450 2C9 exerts a vasoconstrictor influence on coronary resistance vessels in swine at rest and during exercise","volume":"302","author":"Zhou","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.phrs.2018.12.009_bib0415","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/01.CIR.0000105763.51286.7F","article-title":"Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease","volume":"109","author":"Fichtlscherer","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.phrs.2018.12.009_bib0420","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000051064","article-title":"P2X receptor immunoreactivity in different arteries from the femoral, pulmonary, cerebral, coronary and renal circulations","volume":"38","author":"Lewis","year":"2001","journal-title":"J. Vasc. Res."},{"issue":"4 Pt 2","key":"10.1016\/j.phrs.2018.12.009_bib0425","first-page":"F799","article-title":"Localization of P2X1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys","volume":"274","author":"Chan","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"12","key":"10.1016\/j.phrs.2018.12.009_bib0430","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.tips.2007.09.010","article-title":"P2X receptors as regulators of the renal microvasculature","volume":"28","author":"Guan","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2018.12.009_bib0435","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1172\/JCI18499","article-title":"Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior","volume":"112","author":"Inscho","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.phrs.2018.12.009_bib0440","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1476-5381.2010.00914.x","article-title":"Differential effects of uridine adenosine tetraphosphate on purinoceptors in the rat isolated perfused kidney","volume":"161","author":"Tolle","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2018.12.009_bib0445","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1074\/jbc.M109.081166","article-title":"UTP controls cell surface distribution and vasomotor activity of the human P2Y2 receptor through an epidermal growth factor receptor-transregulated mechanism","volume":"285","author":"Norambuena","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2018.12.009_bib0450","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.RES.0000013700.98464.8E","article-title":"Nucleotide receptors involved in UTP-induced rat arterial smooth muscle cell migration","volume":"90","author":"Pillois","year":"2002","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.phrs.2018.12.009_bib0455","doi-asserted-by":"crossref","first-page":"H1751","DOI":"10.1152\/ajpheart.2000.278.6.H1751","article-title":"P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes","volume":"278","author":"Sauzeau","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2-3","key":"10.1016\/j.phrs.2018.12.009_bib0460","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.vph.2009.04.004","article-title":"Global upregulation of gene expression associated with renal dysfunction in DOCA-salt-induced hypertensive rats occurs via signaling cascades involving epidermal growth factor receptor: a microarray analysis","volume":"51","author":"Benter","year":"2009","journal-title":"Vascul Pharmacol"},{"issue":"3 Pt 2","key":"10.1016\/j.phrs.2018.12.009_bib0465","first-page":"H976","article-title":"Epidermal growth factor: a potent vasoconstrictor in experimental hypertension","volume":"276","author":"Florian","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0470","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/HYPERTENSIONAHA.109.140459","article-title":"Extracellular signal-regulated kinase 1\/2 activation, via downregulation of mitogen-activated protein kinase phosphatase 1, mediates sex differences in desoxycorticosterone acetate-salt hypertension vascular reactivity","volume":"55","author":"Giachini","year":"2010","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.phrs.2018.12.009_bib0475","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1124\/jpet.103.062265","article-title":"Rho\/Rho kinase and phosphoinositide 3-kinase are parallel pathways in the development of spontaneous arterial tone in deoxycorticosterone acetate-salt hypertension","volume":"309","author":"Wehrwein","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0480","doi-asserted-by":"crossref","first-page":"F161","DOI":"10.1152\/ajprenal.00281.2007","article-title":"Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension","volume":"294","author":"Graciano","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2018.12.009_bib0485","doi-asserted-by":"crossref","first-page":"F801","DOI":"10.1152\/ajprenal.00286.2012","article-title":"Immunosuppression preserves renal autoregulatory function and microvascular P2X(1) receptor reactivity in ANG II-hypertensive rats","volume":"304","author":"Guan","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"7","key":"10.1016\/j.phrs.2018.12.009_bib0490","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jacc.2018.05.052","article-title":"Erythrocytes from patients with type 2 diabetes induce endothelial dysfunction via arginase I","volume":"72","author":"Zhou","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0495","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol. Rev."},{"issue":"16","key":"10.1016\/j.phrs.2018.12.009_bib0500","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1111\/bph.13205","article-title":"Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes","volume":"172","author":"Matsumoto","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0505","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1124\/jpet.108.148718","article-title":"Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes","volume":"329","author":"Matsumoto","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0510","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/apha.12281","article-title":"Therapeutic implications of peptide interactions with G-protein-coupled receptors in diabetic vasculopathy","volume":"211","author":"Carrillo-Sepulveda","year":"2014","journal-title":"Acta Physiol (Oxf)"},{"issue":"6","key":"10.1016\/j.phrs.2018.12.009_bib0515","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/HYPERTENSIONAHA.114.04221","article-title":"Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study","volume":"64","author":"van Sloten","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2018.12.009_bib0520","article-title":"Endothelial dysfunction and vascular disease - a thirthieth anniversary update","author":"Vanhoutte","year":"2015","journal-title":"Acta Physiol (Oxf)"},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0525","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MNH.0b013e32833240fc","article-title":"The renal vascular response to diabetes","volume":"19","author":"Carmines","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"1","key":"10.1016\/j.phrs.2018.12.009_bib0530","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1620\/tjem.119.85","article-title":"Production of spontaneous diabetic rats by repetition of selective breeding","volume":"119","author":"Goto","year":"1976","journal-title":"Tohoku J Exp Med"},{"issue":"3","key":"10.1016\/j.phrs.2018.12.009_bib0535","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1476-5381.2011.01276.x","article-title":"Endothelium-mediated control of vascular tone: COX-1 and COX-2 products","volume":"164","author":"Feletou","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2018.12.009_bib0540","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2337\/diab.41.11.1422","article-title":"Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima fatty (OLETF) strain","volume":"41","author":"Kawano","year":"1992","journal-title":"Diabetes"},{"issue":"307","key":"10.1016\/j.phrs.2018.12.009_bib0545","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004235","article-title":"A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes","volume":"7","author":"Warren","year":"2014","journal-title":"Sci. Signal."},{"issue":"11","key":"10.1016\/j.phrs.2018.12.009_bib0550","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.tem.2015.09.003","article-title":"Tyrosine kinase inhibitors and diabetes: a novel treatment paradigm?","volume":"26","author":"Fountas","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.phrs.2018.12.009_bib0555","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/eurheartj\/ehq044","article-title":"Coronary atherosclerosis: extending to the microcirculation?","volume":"31","author":"Panza","year":"2010","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.phrs.2018.12.009_bib0560","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jacc.2012.02.082","article-title":"Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!","volume":"60","author":"Marzilli","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.phrs.2018.12.009_bib0565","doi-asserted-by":"crossref","first-page":"H2198","DOI":"10.1152\/ajpheart.00834.2001","article-title":"Nitric oxide production is maintained in exercising swine with chronic left ventricular dysfunction","volume":"282","author":"Haitsma","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1700","key":"10.1016\/j.phrs.2018.12.009_bib0570","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2015.0422","article-title":"Short- and long-term (trophic) purinergic signalling","volume":"371","author":"Burnstock","year":"2016","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"23","key":"10.1016\/j.phrs.2018.12.009_bib0575","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"30","key":"10.1016\/j.phrs.2018.12.009_bib0580","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.2174\/092986707782793899","article-title":"Role of lysophosphatidylcholine (LPC) in atherosclerosis","volume":"14","author":"Matsumoto","year":"2007","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2018.12.009_bib0585","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.phrs.2018.12.009_bib0590","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrd3444","article-title":"Anti-inflammatory therapeutics for the treatment of atherosclerosis","volume":"10","author":"Charo","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.phrs.2018.12.009_bib0595","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00109-011-0750-6","article-title":"The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation","volume":"89","author":"Schuchardt","year":"2011","journal-title":"J Mol Med (Berl)"},{"issue":"8","key":"10.1016\/j.phrs.2018.12.009_bib0600","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/ndt\/gfq080","article-title":"Dinucleoside polyphosphates: newly detected uraemic compounds with an impact on leucocyte oxidative burst","volume":"25","author":"Schepers","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"issue":"11","key":"10.1016\/j.phrs.2018.12.009_bib0605","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/ATVBAHA.107.144824","article-title":"Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease","volume":"27","author":"Scatena","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.phrs.2018.12.009_bib0610","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/hh2101.098617","article-title":"Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin","volume":"89","author":"Chaulet","year":"2001","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.phrs.2018.12.009_bib0615","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.cardiores.2007.05.019","article-title":"Autocrine expression of osteopontin contributes to PDGF-mediated arterial smooth muscle cell migration","volume":"75","author":"Jalvy","year":"2007","journal-title":"Cardiovasc. Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181831168X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181831168X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:55:45Z","timestamp":1760910945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366181831168X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":123,"alternative-id":["S104366181831168X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.12.009","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}